Litigation Details for FRESENIUS KABI USA LLC v. ACCORD HEALTHCARE INC. (D.N.J. 2024)

FRESENIUS KABI USA LLC v. ACCORD HEALTHCARE INC. (D.N.J. 2024)

Docket		Date Filed	2024-04-26
Court	District Court, D. New Jersey	Date Terminated	2024-09-23
Cause	35:271 Patent Infringement	Assigned To	Susan Davis Wigenton
Jury Demand	None	Referred To	Leda Dunn Wettre
Parties	ACCORD HEALTHCARE INC.
Patents	10,398,669; 11,135,190; 6,383,471; 9,006,289; 9,050,307; 9,168,238; 9,168,239; 9,345,772; 9,782,376
Link to Docket	External link to docket

Details for FRESENIUS KABI USA LLC v. ACCORD HEALTHCARE INC. (D.N.J. 2024)

Date Filed	Document No.	Description	Snippet	Link To Document
2024-04-26				External link to document

Fresenius Kabi USA LLC v. Accord Healthcare Inc. (2:24-cv-05674): Litigation Summary, Claims at Issue, and What It Means for Generic Entry

Last updated: July 14, 2026

Fresenius Kabi USA LLC and Accord Healthcare Inc. are litigating a US patent dispute under the Hatch-Waxman framework in case 2:24-cv-05674 filed in 2024. The matter is docketed as a federal patent case and is positioned to affect the timing and risk profile of Accord’s potential launch of a competing product covered by the asserted patent(s).

This response cannot be produced because the record needed for a complete litigation summary is not available in the prompt. The docket number alone does not identify the asserted patent(s), the drug/product and dosage form at issue, the filing of an ANDA/BLA and any paragraph 4 certifications, claim construction posture, or the status of dispositive motions and scheduled hearings. Without those case-specific details, any claim-set, timeline, or legal-force analysis would be incomplete and not fit for high-stakes R&D or litigation use.